U.S. Machinery Stock News

As the United States market navigates a period of cautious optimism with key indices like the S&P 500 reaching new heights, investors are closely watching for signals from the Federal Reserve and major tech earnings. Amidst this backdrop, small-cap stocks often present unique opportunities for those looking to explore lesser-known companies that could benefit from broader economic trends and sector-specific catalysts.

As the U.S. stock market continues to edge higher, with the S&P 500 reaching new milestones and investor attention focused on Federal Reserve decisions and major tech earnings, dividend stocks remain an attractive option for those seeking steady income amidst market fluctuations. In this environment, a good dividend stock is characterized by its ability to offer consistent payouts and financial stability, providing investors with a reliable income stream even as broader economic conditions...

InMode (NASDAQ:INMD) has had a great run on the share market with its stock up by a significant 10% over the last week...

Cornerstone Bancorp (CNBP) closed out FY 2025 with fourth quarter total revenue of US$11.0 million and basic EPS of US$3.14, alongside net income of US$3.09 million that capped off a year of steady profitability. The company has seen quarterly revenue move from US$9.66 million in Q4 FY 2024 to US$11.0 million in Q4 FY 2025, while basic EPS over that same period went from US$3.02 to US$3.14, supported by a trailing twelve month net profit margin of 25.9% versus 25.7% a year earlier. Taken...

If you are wondering whether Alexander's current share price still offers value, it helps to step back and look at what the recent returns and fundamentals are really telling you. The stock most recently closed at US$239.55, with a 7 day return of 0.5% decline, a 30 day return of 9.8%, year to date return of 9.5%, and a 1 year return of 36.3%, which naturally raises questions about how much of this is already reflected in the price. These moves sit alongside a 3 year return of 27.7% and a 5...

If you are wondering whether Leidos Holdings at around US$187 per share still offers value after a strong run, this article will walk through what the current price might imply. The stock has delivered a 33.6% return over the past year and 96.3% over three years. More recently it has seen a 2.0% decline over 7 days and a 0.7% return over the last month, with a 2.0% return year to date. Investors have been paying close attention to Leidos because of its role as a major government and defense...

If you are wondering whether Denali Therapeutics' current share price lines up with its underlying worth, this review will walk through what the numbers are actually saying about value. The stock last closed at US$21.25, with returns of 21.2% over 7 days, 26.0% over 30 days, 30.6% year to date, but a 9.6% decline over 1 year, a 29.8% decline over 3 years, and a 70.8% decline over 5 years, which can change how investors think about both opportunity and risk. Recent attention on Denali...

If you are wondering whether Hubbell's current share price lines up with its underlying worth, you are not alone. This article is here to walk you through that question step by step. Hubbell shares last closed at US$484.14, with returns of 2.5% over 7 days, 6.4% over 30 days, 4.6% year to date, 18.7% over 1 year, 120.5% over 3 years, and 232.0% over 5 years, which naturally raises questions about what you are paying for today. Recent attention on Hubbell has been driven by ongoing investor...

Shareholders of Kenvue (NYSE:KVUE) are preparing to vote on a proposed sale of the company to Kimberly-Clark. The deal structure includes a mix of cash and Kimberly-Clark shares for Kenvue investors. Proxy advisory firms have recommended that shareholders back the transaction ahead of the vote. The proposal has drawn extra attention because litigation tied to Kenvue products is still ongoing. Kenvue, the consumer health company separated from Johnson & Johnson, sits at the intersection of...

If you are wondering whether Kinsale Capital Group's current share price reflects its true worth, you are not alone in asking that question. The stock recently closed at US$386.67, with returns of a 4.6% decline over 7 days, a 1.7% decline over 30 days, a 1.5% decline year to date, gains of 39.5% over 3 years and 108.3% over 5 years, while the last 12 months show a 12.4% decline. Recent attention around Kinsale Capital Group has focused on its share price performance and how investors are...

Several law firms have announced investigations into Nutanix (NasdaqGS:NTNX) over potential securities law violations. The probes follow Nutanix's recent disclosure of a revenue shift and a downward revision to its full year revenue guidance. These developments come as Nutanix shares trade at $41.24, with recent returns under pressure. Nutanix, trading under NasdaqGS:NTNX, is back in focus after its updated revenue outlook and guidance cut triggered legal scrutiny from multiple firms. The...

Analysts are raising concerns that expiring Medicare telehealth reimbursement provisions could change how at-home virtual care visits are paid for, affecting Teladoc Health's (NYSE:TDOC) revenue mix. At the same time, BetterHelp, Teladoc's online therapy platform, is seeing a drop in monthly active users that analysts link to softer consumer sentiment. Together, these reimbursement questions and user trends are putting fresh attention on Teladoc's demand outlook across both medical and...

If you are wondering whether Costamare's current share price reflects its true worth, you are not alone. Many investors are asking the same question. Costamare's stock recently closed at US$16.33, with returns of 5.8% over 7 days, 3.9% over 30 days, 4.1% year to date, 98.0% over 1 year, 145.6% over 3 years and 241.2% over 5 years. Recent news around the container shipping and broader transportation sector has kept attention on companies like Costamare, as investors weigh supply chain trends,...

Corvus Pharmaceuticals reported positive Phase 1 results for soquelitinib in moderate to severe atopic dermatitis, including patients who had limited response to prior therapies. The trial showed encouraging efficacy and safety data, prompting the company to outline plans for a larger Phase 2 study. Corvus expects to begin enrolling patients in the Phase 2 trial in early 2026. For investors tracking Corvus Pharmaceuticals, ticker NasdaqGM:CRVS, this update comes with the stock at $22.08 and...

WEX (NYSE:WEX) has launched a single fleet card that can be used for both traditional fuel purchases and public EV charging. The company has also entered a virtual card partnership with Nuvei to serve global travel merchants. For investors tracking NYSE:WEX, these product moves come with the stock trading at $156.7. Recent returns show a mixed picture, with the share price up 3.2% over the past week and 5.6% year to date, but with a 1-year return of a 13.7% decline and a 3-year return of a...

Northwest Bancshares (NWBI) has put up a solid finish to FY 2025, with Q4 total revenue of US$172.2 million and basic EPS of US$0.31. The company also reported trailing 12 month revenue of US$599.1 million and EPS of US$0.93, alongside earnings growth of 25.8% over the last year. Over recent periods the company has seen total revenue move from US$498.1 million on a trailing basis in Q4 2024 to US$599.1 million in Q4 2025, while trailing EPS has gone from US$0.79 to US$0.93 as net margin held...

First Busey Corporation (NasdaqGS:BUSE) has completed a multi year share repurchase program, retiring over 10% of its outstanding shares since 2015. The company announced the conclusion of the buyback alongside its latest annual earnings report. The end of the program marks a key capital allocation milestone that may influence future earnings per share calculations. First Busey, the holding company for Busey Bank, operates as a regional financial services provider with a focus on community...

If you are wondering whether ACV Auctions' share price reflects its underlying value, this article walks through the key numbers that matter to you as a long term investor. The stock last closed at US$8.35, with returns of 1.1% over 30 days, a 0.7% gain year to date, but a 60.9% decline over the past year and a 14.8% decline over three years. Recent market attention has focused less on headlines and more on how ACV Auctions' business model and sector exposure stack up against peers. This has...

BlackSky Technology Inc. ( NYSE:BKSY ) shares have had a really impressive month, gaining 39% after a shaky period...

Key Insights Significantly high institutional ownership implies Neuronetics' stock price is sensitive to their trading...

Community Financial System (CBU) has just closed out FY 2025 with fourth quarter revenue of US$210.5 million and basic EPS of US$1.03, while trailing twelve month revenue came in at US$796.7 million and EPS at US$3.98. The company has seen revenue move from US$190.1 million and EPS of US$0.94 in Q4 2024 to US$210.5 million and EPS of US$1.03 in Q4 2025. This gives investors a clear view of both quarterly and full year earnings power as they weigh the new numbers against the current share...

ASGN (NYSE:ASGN) has acquired Quinnox, a digital services company, adding digital engineering capabilities and global delivery to its portfolio. The company plans to consolidate its various brands under a new corporate name, Everforth, as part of a broad rebranding effort. These moves represent a material shift in ASGN’s operating structure and brand identity that has not been covered in our prior discussions. ASGN, known for IT services and professional staffing, is leaning further into...

New Fortress Energy (NFE) is back in focus after outlining a proposed restructuring to address cash flow pressures, while simultaneously pursuing South American partnerships and LNG technology projects that sit alongside ongoing losses and a sizeable debt load. See our latest analysis for New Fortress Energy. The proposed restructuring and South American LNG projects come after a volatile period, with a 30 day share price return of 18.80% and a year to date share price return of 25.23%...

Provident Financial Holdings (PROV) has put up a quiet quarter on the top line, with Q2 2026 revenue at US$10.0 million and basic EPS of US$0.22, supported by trailing twelve month figures of US$40.8 million in revenue and EPS of about US$1.00. Over the last few quarters, revenue has moved within a tight band from US$9.0 million in Q2 2025 to US$10.7 million in Q3 2025, while quarterly EPS has ranged from US$0.13 to US$0.28. This leaves investors to focus on how the latest print fits into...